北美肺活量计市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（手持式肺活量计、台式肺活量计和台式肺活量计）、技术（容量、流量和峰值流量）和应用（哮喘、慢性阻塞性肺疾病）疾病、囊性纤维化等）
No. of Pages: 119 | Report Code: BMIRE00026964 | Category: Life Sciences
No. of Pages: 119 | Report Code: BMIRE00026964 | Category: Life Sciences
北美肺活量计市场预计将从2022年的3.9253亿美元增长到762.94美元到 2028 年将达到 100 万。预计 2022 年至 2028 年复合年增长率为 11.7%。
呼吸系统疾病的患病率较高与老年人口上呼吸道管腔尺寸的减小有关。肺部疾病是最常见的疾病之一。此外，吸烟、遗传因素和感染是导致呼吸道疾病的常见因素。各种医疗状况，例如哮喘和慢性阻塞性肺病（COPD）、慢性支气管炎、囊性纤维化和肺癌，都是重大的公共卫生负担。根据美国卫生与公共服务部的数据，2019 年美国有 2500 万人患有哮喘，这是已知的最常见的呼吸道疾病。随着发展中国家吸烟率的不断上升以及高收入国家人口的老龄化，预计未来四十年慢性阻塞性肺病的发病率将会上升。患有呼吸系统疾病的患者通常会出现呼吸困难。
此外，早期发现和诊断可以帮助治疗呼吸系统疾病患者。在这种情况下，肺活量测定是一项关键技术，有助于了解感染的严重程度并避免误诊。因此，随着此类呼吸系统疾病发病率的增加，市场正在出现积极增长。
北美肺活量计市场细分 ;
北美肺活量计市场细分为类型、技术、应用和国家。根据类型，市场分为手持式肺活量计、台式肺活量计和台式肺活量计。 2022 年，台式肺活量计在市场中占据主导地位。根据技术，市场分为容量、流量和峰值流量。 2022 年，流量细分市场在市场中占据主导地位。根据应用，市场分为哮喘、慢性阻塞性肺病、囊性纤维化等。 慢性阻塞性肺疾病细分市场在 2022 年占据主导地位。市场根据国家/地区分为美国、加拿大和墨西哥。此外，美国将在 2022 年主导市场。
一些主要参与者主导北美肺活量计市场是百特国际公司；本森医疗器械有限公司；科斯梅德有限公司；德皮斯蒂奥有限责任公司；亨利·沙因公司； ICU 医疗公司；琼斯医疗器械公司； NUVOAIR US, INC.（NUVOAIR AB）；泰利福公司；和 VYAIRE 医疗有限公司
Strategic insights for North America Spirometer involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 392.53 Million |
| Market Size by 2028 | US$ 762.94 Million |
| Global CAGR (2022 - 2028) | 11.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Spirometer refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Some of the leading companies are:
The North America Spirometer Market is valued at US$ 392.53 Million in 2022, it is projected to reach US$ 762.94 Million by 2028.
As per our report North America Spirometer Market, the market size is valued at US$ 392.53 Million in 2022, projecting it to reach US$ 762.94 Million by 2028. This translates to a CAGR of approximately 11.7% during the forecast period.
The North America Spirometer Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Spirometer Market report:
The North America Spirometer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Spirometer Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Spirometer Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Spirometer Market
